The OZEM ETFs portfolio includes companies actively involved in GLP-1 & Weight Loss, including: What are GLP-1 Drugs
Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine
Increased feelings of fullness: These medications may slow the emptying of the stomach, promoting a sense of fullness and reducing hunger
This presentation begins by surveying some of the trends in the terms of these debates over the last century and the changes in prevailing wisdom about the various balances referred to above
Visit our contact page or call us at 419.265.0404 to speak with a specialist who can guide you in choosing the right product for your needs
Also see our Top Picks for protein powders and Top Picks for collagen